Expand BIAFW Menu
BIAFW MENU

BIAFW Latest Press Releases

-- January 7, 2026 --

bioAffinity Technologies' Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation Business Wire 8:00 AM

-- December 3, 2025 --

bioAffinity Technologies' Noninvasive CyPath Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable Business Wire 8:00 AM

-- November 14, 2025 --

bioAffinity Technologies Reports Third Quarter 2025 Financial Results Business Wire 8:00 AM

-- November 5, 2025 --

bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath Lung Test Volume Business Wire 8:00 AM

-- October 28, 2025 --

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases Business Wire 8:00 AM

-- October 20, 2025 --

bioAffinity Technologies Presents Research Supporting CyPath Lung Processing Methods at CHEST 2025 Business Wire 8:00 AM

-- October 16, 2025 --

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer Business Wire 8:00 AM

-- October 15, 2025 --

bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements Business Wire 8:00 AM

-- October 9, 2025 --

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules Business Wire 1:00 PM

-- October 8, 2025 --

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules Business Wire 3:45 PM

-- October 7, 2025 --

bioAffinity Technologies Reports Record Growth in CyPath Lung Test Volume for Third Quarter 2025 Business Wire 8:00 AM

-- September 30, 2025 --

bioAffinity Technologies Announces Closing of $4.8 Million Public Offering Business Wire 12:15 PM

-- September 29, 2025 --

bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering Business Wire 3:51 PM

-- September 26, 2025 --

bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath Lung Business Wire 8:00 AM

-- September 17, 2025 --

bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025 Business Wire 8:15 AM

-- September 9, 2025 --

Case Study: CyPath Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules Business Wire 8:00 AM

-- September 3, 2025 --

U.S. Medicine Magazine Spotlights CyPath Lung as Promising Tool to Improve Lung Cancer Detection in Veterans, Lower Costs to the VA Business Wire 8:00 AM

-- August 18, 2025 --

bioAffinity Technologies Appoints New Members to Board of Directors Business Wire 8:00 AM
Market Data Delayed 15 Minutes